the united states have just authorized the release of a new anti-obesity treatment: LORCASERIN Has
ignored important safety information , denounces the US consumer advocacy group Public Citizen
Like several other drugs for the weight loss in the past, it will in turn be taken off the market after the agency faces several unhealthy side effects such as
damage to the heart valves.
The FDA voted in favor
but reluctantly due to widely shared concerns about signs of heart valve damage in people using the drug in clinical trials.